Superenhancer Drives a Tumor-Specific Splicing Variant of MARCO to Promote Triple-Negative Breast Cancer Progression

Scientists presented a comprehensive analysis of RNA splicing in breast cancer to illustrate the biological function and clinical implications of tumor-specific transcripts arising from these splicing junctions.